HK Stock MarketDetailed Quotes

06622 ZHAOKE OPHTH-B

Watchlist
  • 1.290
  • -0.040-3.01%
Market Closed Dec 20 16:08 CST
704.52MMarket Cap-2.83P/E (TTM)

ZHAOKE OPHTH-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q9)Sep 30, 2020
(FY)Dec 31, 2019
Turnover
340.28%49.77M
--18.75M
--11.3M
----
----
----
----
----
----
----
Operating income
340.28%49.77M
18.75M
11.3M
Cost of sales
-502.52%-6.93M
---4.5M
---1.15M
----
----
----
----
----
----
----
Operating expenses
-502.52%-6.93M
-4.5M
-1.15M
Gross profit
321.90%42.84M
14.25M
10.15M
Selling expenses
-23.07%-28.4M
-73.28%-51.89M
-68.97%-23.08M
-78.93%-29.95M
-107.98%-13.66M
-985.34%-16.74M
---6.57M
---1.54M
----
----
Administrative expenses
26.47%-31.3M
1.98%-84.4M
-7.74%-42.57M
46.87%-86.11M
60.73%-39.51M
-363.06%-162.08M
---100.61M
-454.62%-35M
-145.52%-9M
-447.83%-6.31M
Research and development expenses
56.27%-89.8M
-12.35%-333.05M
-103.46%-205.35M
-34.71%-296.43M
18.23%-100.93M
-169.09%-220.06M
---123.44M
12.45%-81.78M
26.81%-54.72M
-168.50%-93.41M
Special items of operating profit
14.20%35.67M
844.99%78.53M
655.41%31.24M
-75.94%8.31M
-176.57%-5.62M
-45.15%34.54M
--7.35M
1,465.37%62.98M
-26.41%2.12M
942.23%4.02M
Operating profit
69.08%-70.99M
6.83%-376.57M
-43.75%-229.6M
-10.94%-404.18M
28.46%-159.72M
-558.26%-364.33M
-223.27M
42.16%-55.35M
18.46%-61.6M
-169.15%-95.7M
Financing cost
-32.36%-4.81M
-152.10%-7.92M
-178.27%-3.64M
-61.21%-3.14M
99.93%-1.31M
-17.76%-1.95M
---1.76B
93.73%-1.66M
-3,421.65%-513.88M
-1,889.59%-26.38M
Special items of earning before tax
----
----
----
----
----
-163.22%-1.76B
----
---669.98M
----
----
Earning before tax
67.50%-75.8M
5.60%-384.49M
-44.84%-233.24M
80.88%-407.32M
91.90%-161.03M
-192.96%-2.13B
-1.99B
-495.51%-726.98M
-538.41%-575.48M
-231.00%-122.08M
Tax
----
---550K
---540K
----
----
----
----
----
----
----
After-tax profit from continuing operations
67.58%-75.8M
5.47%-385.04M
-45.18%-233.78M
80.88%-407.32M
91.90%-161.03M
-192.96%-2.13B
-1.99B
-495.51%-726.98M
-538.41%-575.48M
-231.00%-122.08M
Earning after tax
67.58%-75.8M
5.47%-385.04M
-45.18%-233.78M
80.88%-407.32M
91.90%-161.03M
-192.96%-2.13B
-1.99B
-495.51%-726.98M
-538.41%-575.48M
-231.00%-122.08M
Profit attributable to shareholders
67.58%-75.8M
5.47%-385.04M
-45.18%-233.78M
80.88%-407.32M
91.90%-161.03M
-192.96%-2.13B
-1.99B
-495.51%-726.98M
-538.41%-575.48M
-231.00%-122.08M
Basic earnings per share
67.44%-0.14
5.33%-0.71
-43.33%-0.43
85.47%-0.75
95.73%-0.3
-7.28%-5.16
-7.02
-4.81
Diluted earnings per share
67.44%-0.14
5.33%-0.71
-43.33%-0.43
85.47%-0.75
95.73%-0.3
-7.28%-5.16
-7.02
-4.81
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
KPMG
--
KPMG
--
KPMG
--
KPMG
--
KPMG
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q9)Sep 30, 2020(FY)Dec 31, 2019
Turnover 340.28%49.77M--18.75M--11.3M----------------------------
Operating income 340.28%49.77M18.75M11.3M
Cost of sales -502.52%-6.93M---4.5M---1.15M----------------------------
Operating expenses -502.52%-6.93M-4.5M-1.15M
Gross profit 321.90%42.84M14.25M10.15M
Selling expenses -23.07%-28.4M-73.28%-51.89M-68.97%-23.08M-78.93%-29.95M-107.98%-13.66M-985.34%-16.74M---6.57M---1.54M--------
Administrative expenses 26.47%-31.3M1.98%-84.4M-7.74%-42.57M46.87%-86.11M60.73%-39.51M-363.06%-162.08M---100.61M-454.62%-35M-145.52%-9M-447.83%-6.31M
Research and development expenses 56.27%-89.8M-12.35%-333.05M-103.46%-205.35M-34.71%-296.43M18.23%-100.93M-169.09%-220.06M---123.44M12.45%-81.78M26.81%-54.72M-168.50%-93.41M
Special items of operating profit 14.20%35.67M844.99%78.53M655.41%31.24M-75.94%8.31M-176.57%-5.62M-45.15%34.54M--7.35M1,465.37%62.98M-26.41%2.12M942.23%4.02M
Operating profit 69.08%-70.99M6.83%-376.57M-43.75%-229.6M-10.94%-404.18M28.46%-159.72M-558.26%-364.33M-223.27M42.16%-55.35M18.46%-61.6M-169.15%-95.7M
Financing cost -32.36%-4.81M-152.10%-7.92M-178.27%-3.64M-61.21%-3.14M99.93%-1.31M-17.76%-1.95M---1.76B93.73%-1.66M-3,421.65%-513.88M-1,889.59%-26.38M
Special items of earning before tax ---------------------163.22%-1.76B-------669.98M--------
Earning before tax 67.50%-75.8M5.60%-384.49M-44.84%-233.24M80.88%-407.32M91.90%-161.03M-192.96%-2.13B-1.99B-495.51%-726.98M-538.41%-575.48M-231.00%-122.08M
Tax -------550K---540K----------------------------
After-tax profit from continuing operations 67.58%-75.8M5.47%-385.04M-45.18%-233.78M80.88%-407.32M91.90%-161.03M-192.96%-2.13B-1.99B-495.51%-726.98M-538.41%-575.48M-231.00%-122.08M
Earning after tax 67.58%-75.8M5.47%-385.04M-45.18%-233.78M80.88%-407.32M91.90%-161.03M-192.96%-2.13B-1.99B-495.51%-726.98M-538.41%-575.48M-231.00%-122.08M
Profit attributable to shareholders 67.58%-75.8M5.47%-385.04M-45.18%-233.78M80.88%-407.32M91.90%-161.03M-192.96%-2.13B-1.99B-495.51%-726.98M-538.41%-575.48M-231.00%-122.08M
Basic earnings per share 67.44%-0.145.33%-0.71-43.33%-0.4385.47%-0.7595.73%-0.3-7.28%-5.16-7.02-4.81
Diluted earnings per share 67.44%-0.145.33%-0.71-43.33%-0.4385.47%-0.7595.73%-0.3-7.28%-5.16-7.02-4.81
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --KPMG--KPMG--KPMG--KPMG--KPMG

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
HK
Overall
Symbol
Price
% Chg

No Data

Investment Theme Pharmaceutical Companies
Pharmaceutical Companies
Intraday-0.05%